COL14A1 aberrant methylation has been reported in ESCC [16], as well as in renal cell carcinoma, sarcomas, and endometrial carcinoma [27, 30, 31], whereas hypomethylation has been shown in coronary artery disease [32]. This evidence concerns the gene COL14A1 and endometrial carcinoma.